TBXT and neoplasm: Additional markers—such as tumor neoantigen burden, deficient mismatch repair, microsatellite instability-high, T-cell receptor clonality, tumor-infiltrating lymphocytes, DNA damage and repair genes, and effector T-cell gene signatures—have also been investigated [11,12].